Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma: Houston Thursday, January 30, 2025, 17:00 Hrs [IST] ...
BALTIMORE, MD / ACCESS Newswire / January 30, 2025 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published ...
The billboards led to a lot of attention from the media, and the rising star soon began to receive offers for movie roles and ...
Alterity plans to seek US FDA fast-track approval after posting positive phase II results for multiple system atrophy treatment. ... Read More The post Health Check: Alterity angles for fast-track FDA ...
Clinically Meaningful Benefit Observed at Both ATH434 Doses Studied –– Achieved Statistical Significance with Up to 48% Slowing of Clinical ...
To report SUSPECTED ADVERSE REACTIONS, contact Zevra Therapeutics, Inc. at toll-free phone 1-844-600-2237 or FDA at 1‐800-FDA-1088 or .
Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. MALMÖ, SE / ACCESS Newswire / January ...
The best Netflix original series right now include American Primeval, The Night Agent, Black Doves, The Madness, A Man on the Inside, Territory, and more.
The "Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Application Training Course" conference has been added to ResearchAndMarkets.com's offering. The Common ...
PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological ...
It has almost become a pattern in Sri Lanka that regime changes are followed by scandals, which undermine public trust in the new governments. The UNP-led Yahapalana administration, which came to ...